CD80 and leukemia: These results demonstrate that the potency of adoptively transferred, CD19-targeted T cells dependent of CD28/CD80-costimulation, is increased by CTLA-4 blockade and establish for the first time that 19-28z+ T cells, which prolong survival of animals bearing aggressive leukemia, are not sensitive to CTLA-4 inhibition.